Composition
- Active ingredients
- CHLORDIAZEPOXIDE HYDROCHLORIDE 25MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Strengths and forms
The FDA lists each strength of a product separately; these pages share one label.
- CHLORDIAZEPOXIDE HYDROCHLORIDE 25MG · CapsuleANDA085475-001 · Prescription
- CHLORDIAZEPOXIDE HYDROCHLORIDE 100MG/AMP · InjectableNDA012301-001 · Discontinued
- CHLORDIAZEPOXIDE HYDROCHLORIDE 5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · CapsuleNDA012249-002 · Discontinued
- CHLORDIAZEPOXIDE HYDROCHLORIDE 25MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · CapsuleThis page
- CHLORDIAZEPOXIDE HYDROCHLORIDE 10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · CapsuleNDA012249-001 · Discontinued
- CHLORDIAZEPOXIDE HYDROCHLORIDE 5MG · CapsuleANDA085461-001 · Prescription
- CHLORDIAZEPOXIDE HYDROCHLORIDE 10MG · CapsuleANDA085472-001 · Prescription
Official product information
Drugs@FDA lists the approved labels, letters and reviews for application NDA012249.
At a glance
- Brand name
- Librium
- Active substance
- chlordiazepoxide hydrochloride
- Route
- Oral
- Dosage form
- Capsule
- Applicant
- Valeant Pharm Intl
- Status
- Discontinued
- FDA approval
- 24 Feb 1960
- Application
- NDA012249-003